Literature DB >> 18968891

High-performance liquid chromatographic method for simultaneous determination of honokiol and magnolol in rat plasma.

Xinan Wu1, Xingguo Chen, Zhide Hu.   

Abstract

A high-performance liquid chromatographic (HPLC) method is described for the simultaneous determination of honokiol and magnolol in rat plasma. The plasma was deproteinized with acetonitrile which contained an internal standard (diphenyl) and was separated from the aqueous layer by adding sodium chloride. Honokiol and magnolol are extracted into the acetonitrile layer with high yield, and determined by reversed-phase HPLC and ultraviolet detection. The limits of quantitation for honokiol and magnolol were 13 and 25 ngml(-1) in plasma, respectively, and recovery of both analytes was greater than 93%. The assay was linear from 20 to 200 ngml(-1) for honokiol and from 40 to 400 ngml(-1) for magnolol. Variation over the range of the standard curve was less than 15%. The method was used to determine the concentration-time profiles of honokiol and magnolol in the plasma following rectal administration of Houpo extract at a dose of 245 mgkg(-1), equivalent to 13.5, 24.4 mgkg(-1) of honokiol and magnolol, respectively.

Entities:  

Year:  2003        PMID: 18968891     DOI: 10.1016/s0039-9140(02)00470-8

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  7 in total

1.  Separation and determination of honokiol and magnolol in Chinese traditional medicines by capillary electrophoresis with the application of response surface methodology and radial basis function neural network.

Authors:  Ping Han; Feng Luan; Xizu Yan; Yuan Gao; Huitao Liu
Journal:  J Chromatogr Sci       Date:  2012-01       Impact factor: 1.618

Review 2.  Honokiol: a novel natural agent for cancer prevention and therapy.

Authors:  S Arora; S Singh; G A Piazza; C M Contreras; J Panyam; A P Singh
Journal:  Curr Mol Med       Date:  2012-12       Impact factor: 2.222

3.  Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.

Authors:  Xianhuo Wang; Xingmei Duan; Guangli Yang; Xiaoyan Zhang; Linyu Deng; Hao Zheng; Chongyang Deng; Jiaolin Wen; Ning Wang; Cheng Peng; Xia Zhao; Yuquan Wei; Lijuan Chen
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

4.  Ionic liquids functionalized β-cyclodextrin polymer for separation/analysis of magnolol.

Authors:  Nan Zhou; Xia-Shi Zhu
Journal:  J Pharm Anal       Date:  2013-12-28

5.  Effect of feeding Chinese herb medicine ageratum-liquid on intestinal bacterial translocations induced by H9N2 AIV in mice.

Authors:  Haoran Lu; Luxuan Zhang; Junfang Xiao; Che Wu; Huanmin Zhang; Yihu Chen; Zhengyong Hu; Wencheng Lin; Qingmei Xie; Hongxin Li
Journal:  Virol J       Date:  2019-02-21       Impact factor: 4.099

Review 6.  Honokiol: A Review of Its Anticancer Potential and Mechanisms.

Authors:  Chon Phin Ong; Wai Leong Lee; Yin Quan Tang; Wei Hsum Yap
Journal:  Cancers (Basel)       Date:  2019-12-22       Impact factor: 6.639

7.  Cardiovascular protection of magnolol: cell-type specificity and dose-related effects.

Authors:  Jennifer Hui-Chun Ho; Chuang-Ye Hong
Journal:  J Biomed Sci       Date:  2012-07-31       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.